RI cyberattack could expose data of 650,000 people - more than half state's population
The hackers behind the attack on the state network known as RIBridges and UHIP, remain unidentified, and their ransom demands have not been made public.
When the system was shut down Dec. 13, McKee said the state expected that personal data of those who had used the system would be released last week. As of Monday afternoon, the state had received "no indications" that any private data had been distributed.
But Chief Information Officer Brian Tardiff said Monday that there was "no indications or reports" from Deloitte, the private information technology vendor running the system, "that the information has been released on the dark web."
"I think it's important to remember that the data has been taken already, and just because they have not released it doesn't mean that this information is not already on the dark web," he said.
State policy reflected in Deloitte's contract requires that vendors encrypt private data they manage, and the state is working to confirm that personal information on RIBridges was encrypted, said Laura Hart, a spokesperson for McKee.
The 650,000-person estimate includes anyone who applied for benefits through the state system since it launched in 2016, even if they did not actually receive benefits.
Deloitte and state officials are working to secure the system so that it can be relaunched. Tardiff said they expect that will happen sometime in January.
The RIBridges/UHIP system was built to centralize and automate the process of applying for state benefits and determining who does not qualify for them.
More: RI benefits cyberattack is still playing out. Here's what the state has done, and what you can do.
With the system down, the state has paused terminations for Medicaid, Supplemental Nutrition Assistance (SNAP) and other public programs.
Residents can still apply for benefits by paper.
Benefits scheduled to be distributed Jan. 1 will be paid on time, Department of Human Services Director Kimberly Merolla-Brito said.
The RIBridges breach also shut down Rhode Island's public health insurance exchange during the open enrollment period.
In response, HealthSource RI is extending the open enrollment period through Feb. 28, Director Lindsay Lang said.
Anyone who needs to sign up for coverage starting on Jan. 1 is encouraged to call the HealthSource call center at 855-840-4774. There's also a new webpage with more information: healthsourceri.com/covered2025.
"We'll help you enroll directly through Blue Cross Blue Shield of Rhode Island or Neighborhood Health Plan of Rhode Island Island with a Jan. 1 coverage date," Lang said. "You will not be responsible for premiums while temporarily involved in this program, and our carriers are working to limit out-of-pocket costs that customers will face in the months of January and February, like copays and deductibles."
This article originally appeared on The Providence Journal: RI cyberattack could expose data of 650,000 people. What to know.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
TD Cowen Reiterates Buy Rating on Molina Healthcare (MOH) Stock
Molina Healthcare, Inc. (NYSE:MOH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 28, Ryan Langston, an analyst from TD Cowen, reiterated a 'Buy' rating on the company's stock, and the associated price target was lowered to $203.00. The analyst noted that Molina Healthcare, Inc. (NYSE:MOH) continues to effectively manage the medical costs in the challenging environment, mainly in Medicaid, where it is witnessing pressures in behavioral, pharmacy, and inpatient/outpatient care. A doctor in scrubs shaking hands with a patient, representing the healthcare services provided to individuals and families. Molina Healthcare, Inc. (NYSE:MOH) continues to actively work with state partners in order to restore Medicaid rates to appropriate levels. It has considered increased cost trends in the Medicare and Marketplace bids for 2026. Despite challenges, Molina Healthcare, Inc. (NYSE:MOH)'s strategic efforts and adjustments in rate filings reflect growth potential, justifying the analyst's rating. For FY 2025, the Premium revenue is expected to be ~$42 billion, reflecting an increase of ~9% from FY 2024. Molina Healthcare, Inc. (NYSE:MOH) expects its FY 2025 GAAP earnings to be no less than $16.90 per diluted share. Oakmark Funds, advised by Harris Associates, released its Q2 2025 investor letter. Here is what the fund said: 'Molina Healthcare, Inc. (NYSE:MOH) is a leading managed care company. The company is the fourth largest player in managed Medicaid and has consistently delivered industry-leading margins historically. In our view, this is thanks to Molina Healthcare's exceptional management team and culture of operational excellence. Moreover, we think Molina Healthcare has a long runway for growth given its small scale relative to peers and untapped opportunities in their Medicare and Marketplace business segments. Recently, the Medicaid industry has come under substantial pressure due to a challenging redetermination cycle and additional headwinds from legislation under the current administration. This provided the opportunity to, in our view, purchase shares in a best-in-class managed care company at depressed valuation on trough earnings.' While we acknowledge the potential of MOH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 hours ago
- Yahoo
Prediction: Nvidia's New China Deal Will Be a Game-Changer. Here's Why
Key Points While most of Nvidia's revenue hails from the U.S. and Europe, the Chinese market represents an estimated $50 billion opportunity. Recent changes to tariff policies and export controls have stifled Nvidia's potential in China throughout 2025. Nvidia and the U.S. government have formed a deal structure that helps pave the way for Nvidia to reclaim dominance in the key Asian market. 10 stocks we like better than Nvidia › Although it's only August, 2025 has already played out like a modern-day Greek tragedy for semiconductor powerhouse Nvidia (NASDAQ: NVDA). Its year has been marked by a litany of setbacks, comebacks, and everything in between. Earlier this year, more than $1 trillion of Nvidia's market value was wiped out. Yet today, the company boasts a market cap of $4.4 trillion -- reclaiming the crown as the most valuable company in the world. At the center of Nvidia's headaches in 2025 is China -- and no, not because of DeepSeek. The real culprit has been a wave of sweeping tariff policies and export controls that have curtailed Nvidia's influence in the Chinese AI market. Now, after months of negotiations with regulators in Washington, it appears that the tide may be turning. Nvidia could be on the precipice of reestablishing its presence in one of its most crucial Asian markets. Let's unpack the details of Nvidia's new deal structure in China and examine why it should be celebrated as a massive win for investors. How big an opportunity is China for Nvidia? According to accounting and consulting firm Deloitte, the global total addressable market (TAM) for semiconductors, as measured by sales, reached $627 billion in 2024. Deloitte projects that the market will grow at a compound annual growth rate (CAGR) of 19% over the coming decades -- ultimately reaching $2 trillion by 2040. Outside of the U.S., China remains one of the most important markets fueling demand for high-performance chipsets, particularly graphics processing units (GPUs). Nvidia CEO Jensen Huang has estimated that the AI opportunity in China alone could be worth as much as $50 billion. In 2024, Nvidia generated $130 billion in revenue, with China capturing roughly 13% of this sum. During the first quarter of 2025, Nvidia's $5.5 billion of China sales accounted for roughly 12.5% of total revenue. This leveling trend underscores how the current administration's policies toward China have started to constrain Nvidia's growth potential in the region. Why is Nvidia's new China deal so important? According to multiple news outlets, Nvidia has reached an agreement with Washington regarding its operation in China. Under the terms, Nvidia will pay 15% of its China-based sales to the U.S. government. In effect, the arrangement provides Nvidia with a pathway to penetrate this critical market through its tailored H20 chips. While this might initially resemble a tax, investors should avoid viewing it through that lens. First, the agreement applies to sales of Nvidia's AI chips rather than to profits, unlike traditional forms of taxation. Moreover, the 15% rate does not appear to be variable in structure like a royalty, which is typically tied to intellectual property (IP) and subject to fluctuate. While this deal might appear unusual at first glance, these structures are not without precedent in global business practices. For example, energy companies that extract natural resources or commodities in foreign countries often operate under similar revenue-sharing agreements with host nations in exchange for distribution rights. In my view, dedicating a modest share of sales to secure access to China represents a strategic trade-off. In the long run, it allows Nvidia to preserve its dominant position in one of the world's most important AI markets and prevents domestic rivals such as Huawei from eroding its competitive moat. Is Nvidia stock a buy? While Nvidia's forward price-to-earnings (P/E) ratio has been expanding recently, levels remain muted compared to peaks reached previously during the AI revolution. In my view, part of this multiple compression reflects concerns surrounding China -- perhaps overly so. Nvidia's new agreement in Washington offers the company renewed momentum, securing revenue in a critical market without forfeiting much in the way of profits -- even with the 15% remittance to the U.S. government. Over the long term, I see this arrangement as a strategic mechanism for Nvidia to strengthen its position overseas and deliver durable growth across the global AI infrastructure market. As these fundamentals take hold, I think the company's valuation multiples could expand further, potentially driving the stock to new highs sooner than many investors may be expecting. For that reason, I see Nvidia stock as a no-brainer opportunity to buy hand over fist right now and hold for years to come. Do the experts think Nvidia is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Nvidia make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,070% vs. just 184% for the S&P — that is beating the market by 885.55%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Adam Spatacco has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Prediction: Nvidia's New China Deal Will Be a Game-Changer. Here's Why was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
10 hours ago
- Yahoo
CVS Health Corporation (CVS) Is 'The Last Man Standing,' Says Jim Cramer
We recently published . CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently discussed. CVS Health Corporation (NYSE:CVS) is a pharmaceutical retailer whose shares are among the top performers in the industry. They have gained 55% year-to-date and are up by 16.8% since late July. CVS Health Corporation (NYSE:CVS) has performed well on the stock market as its rivals continue to struggle. In his previous remarks about the firm, Cramer has commented on the competitive dynamics and speculated that the stock could go even higher. Here are his latest comments about CVS Health Corporation (NYSE:CVS): '[On a Baird upgrade] I think that they are the last man standing, with Rite Aid pulling back and Walgreen, they're shutting a huge amount of Walgreen since they were sold. I think that by the way, David Joiner, non-promotional. Did a remarkable job in terms of health insurance. They are the one to bet on if you want to be in that area. I don't want to be in that area after reading Semblest let's just put a gun to my head with five bullets I don't want to go there, just bad ratio.' Previously, Cramer discussed CVS Health Corporation (NYSE:CVS)'s stock price: 'Right, and remember, Walgreens shrinkings, Rite-Aid gone away, 185 million people now go to these, including 60 million people who use two or more of their offerings. David, I've got to tell you, they are, if you remember, the one that was the worst, they're now the first. David Joiner, congratulations, you know how to price your business. And, they're getting out of the individual exchange plans in 2026. Goodbye Medicaid? 'Guidance goes, six, six twenty, from five seventy five, six dollars, there's a stock that going to . . .one hundred dollars!' While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
